Skip to main content
SpringerLink
Log in

Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype

  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

Human tumor cells have properties in vitro or in surrogate hosts that are distinct from those of normal cells, such as immortality, anchorage independence, and tumor formation in nude mice. However, different cells from individual tumors may exhibit some, but not all of these features. In previous years, human tumor cell lines derived from different tumor and tissue types have been studied to determine those molecular changes that are associated with the in vitro properties listed above and with tumorigenicity in nude mice. In the present study, seven cell lines derived from human tumors were characterized for p53 and ras mutations that may occur in SCC tumor phenotypes and for tumor formation in nude mice. This investigation was designed to examine whether co-occurrence of mutated ras and p53 lead to a malignant stage in the progression process. None of the seven cell lines contained mutations in the recognized "hot spots" of the p53 tumor suppressor gene, but four had a nonsense/splice mutation in codon 126 and a mutation in codon 12 of the H-ras gene. The remaining three cell lines had p53 mutations in intron 5, in codon 193, and a missense mutation in codon 126, respectively. Four of seven cell lines were nontumorigenic; two of these cell lines contained a nonsense p53-126 mutation and mutated ras; one had a missense mutation at codon 126 but no mutated ras; the the fourth had only a p53 mutation at codon 193. Two of the nontumorigenic cell lines were converted to tumorigenicity after treatment with methyl methanesulfonate or N-methyl-N′-nitro-N-nitrosoguanidine with no apparent additional mutations in either gene. Our analysis revealed that there was a high frequency of genetic diversity and mutations in both p53 and H-ras. There was also a lack of a causal relationship in the presence of mutations in p53 and the cells‘ ability to exhibit a malignant potential in nude mice.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Addison C, Jenkins JR, Sturzbecher HW. The p53 nuclear localization signal is structurally linked to a p34cdc2 kinase motif. Oncogene. 1990;5:423–6.

    Google Scholar 

  • Baker SJ, Preisinger AC, Jessup JM et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990a;50:7717–22.

    Google Scholar 

  • Baker SJ, Markowitz S, Fearon DR, Wilson JKU, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 1990b;249:912–5.

    Google Scholar 

  • Bos JL. Ras oncogenes in human cancer: a review. Cancer Res. 1989;49:4682–9. [Published erratum appears in Cancer Res. 1990;50:1352].

    Google Scholar 

  • Boukamp P, Peter W, Pascheberg U et al. Step-wise progression in human skin carcinogenesis in vitro involves mutational inactivation of p53, rasH oncogene activation and addi-tional chromosome loss. Oncogene. 1995;11:961–9.

    Google Scholar 

  • Boukamp P, Stanbridge EJ, Foo DY, Cerutti PA, Fusenig NE. c-Ha-ras oncogene expression in immortalized human ker-atinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res. 1990;50:2840–7.

    Google Scholar 

  • Budlowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE. Am J Hum Genet. 1991;48:137–44.

    Google Scholar 

  • Cabrero CA, Diez EV, Carracedo A, Alemany J. Allele frequency distribution of four PCR-amplified loci in the Spanish population. Forens Sci Int. 1995;71:153–64.

    Google Scholar 

  • Cajot J-F, Anderson MJ, Lehman TA, Shapiro H, Briggs AA, Stanbridge EJ. Growth suppression mediated by transfec-tion of p53 in Hut292DM human lung cancer cells expres-sing endogenous wild-type p53 protein. Cancer Res. 1992;52:6956–60.

    Google Scholar 

  • Cariello NF, Cui L, Beroud C, Soussi T. Database and software for the analysis of mutations in the human p53 gene. Cancer Res. 1994;54:4454–60.

    Google Scholar 

  • Caron de Fromentel C, Soussi T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chro-mosomes Cancer. 1992;4:1–15.

    Google Scholar 

  • Chang SE, Bhatia P, Johnson NW et al. ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer. 1991;48:409–12.

    Google Scholar 

  • Chen J, Milo GE, Shuler CF, Schuller DE. Xenograft growth and histodifferentiation of squamous cell carcinomas of the pharynx and larynx. Oral Surg Oral Med Surg Oral Pathol Oral Radiol Endod. 1996;81:197–202.

    Google Scholar 

  • Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumour suppressor-DNA complex: understanding tumorigenic mutations. Science. 1994;265:346–355.

    Google Scholar 

  • Chumakov PM. EMBL data library, Accession Number X54156. 1990.

  • Clore GM, Omichinski JG, Sakaguchi K et al. High-resolution structure of the oligomerization domain of p53 by multi-dimensional NMR. Science. 1994;265:386–91.

    Google Scholar 

  • Diller L, Kassel J, Nelson CE et al. p53 functions as a cell cycle control protein in osteosarcoma. Mol Cell Biol. 1990;10:5772–81.

    Google Scholar 

  • Dittmer D, Pati S, Zambetti G et al. Gain of function mutations in p53. Nature Genet. 1993;4:42–6.

    Google Scholar 

  • Eliyahu D, Raz A, Gruss P, Givol D, Oren M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature. 1984;312:646–9.

    Google Scholar 

  • Finney RE, Bishop JM. Predisposition to neoplastic transfor-mation caused by gene replacement of H-ras. Science. 1993;260:1524–7.

    Google Scholar 

  • Gerwin BI, Spillare E, Forrester K et al. Mutant p53 can induce tumorigenic conversion of human bronchial cells and re-duce their responsiveness to a negative growth factor, transforming growth factor b-1. Proc Natl Acad Sci USA. 1992;89:2759–63.

    Google Scholar 

  • Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855–78.

    Google Scholar 

  • Gyllensten UB, Erlich HA. Generation of single-stranded DNA by the polymerase chain reaction and its application to direct sequencing of the HLA-DQA locus. Proc Natl Acad Sci USA. 1988;85:7652–6.

    Google Scholar 

  • Hall A. A biochemical function for ras-at last. Science. 1994;264:1413–4.

    Google Scholar 

  • Hammond HA, Li Jin YZ, Caskey CT, Chakraborty R. Evaluation of 13 short tandem repeat loci for use in personal identification applications. Am J Hum Genet. 1994;55:175–89.

    Google Scholar 

  • Higuchi R. Simple and rapid preparation of samples for PCR. In: Erlich HA, ed. PCR technology-Principles and applications for DNA amplification. New York: Stockton Press; 1989:31–8.

    Google Scholar 

  • Hinds P, Finlay C, Levine AJ. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J Virol. 1989;63:739–46.

    Google Scholar 

  • Hinds PW, Finlay CA, Quartin RS et al. Mutant p53 cDNAs from human colorectal carcinomas can cooperate with ras in transformation of primary rat cells: a comparison of the “hot spot” mutant phenotypes. Cell Growth Differ. 1990;1:571–80.

    Google Scholar 

  • Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science. 1991;253:49–53.

    Google Scholar 

  • Iggo R, Gatter K, Bartek J, Lane D, Harris AL. Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet. 1990;335:675–9.

    Google Scholar 

  • Jenkins JR, Rudge K, Currie GA. Cellular immortalization by a cDNA clone encoding the transformation-associated phosphoprotein p53. Nature. 1984;312:651–4.

    Google Scholar 

  • Kikuchi-Yanoshita R, Konishi M, Ito S et al. Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adeno-matous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 1992;52:3965–71.

    Google Scholar 

  • Kikuchi-Yanoshita R, Tanaka K, Muraoke M et al. Malignant transformation of rat embryo fibroblasts by cotransfection with eleven human mutant p53 cDNAs and activated H-ras gene. Oncogene. 1995;11:1339–45.

    Google Scholar 

  • La Spada AR, Wilson EM, Lubahn DB, Harding AE, F isch-beck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77–9.

    Google Scholar 

  • Lehman TA, Bennett WP, Metcalf RA et al. p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Res. 1991;51:4090–6.

    Google Scholar 

  • Li D, Noyes I, Shuler CF, Milo GE. Cloning and sequencing of CATR1.3, a human gene associated with tumorigenic con-version. Proc Natl Acad Sci USA. 1995;92:6409–13.

    Google Scholar 

  • Li D, Hua Y, Chen J, Casto BC, Theil KS, Milo GE. Malignant conversion of human cells by antisense cDNA to a putative tumor suppressor gene. Carcinogenesis. 1996;17:1751–5.

    Google Scholar 

  • Mercer WF, Shields MT, Amin M et al. Antiproliferative effects of wild-type human p53. J Cell Biochem. 1990;14C:285.

    Google Scholar 

  • Milo GE, Lee H. Molecular control of expression of plasticity of tumorigenic/metastatic phenotypes. In: Rhim JS, Dritschilo A, eds. Neoplastic transformation in human cell culture. Totowa, NJ: Humana Press; 1991:223–32.

    Google Scholar 

  • Milo GE, Yohn J, Schuller D, Noyes I, Lehman T. Comparative stages of expression of human squamous carcinoma cells and carcinogen transformed keratinocytes. J Invest Dermatol. 1989;92:848–53.

    Google Scholar 

  • Milo GE, Shuler C, Kurian P et al. Nontumorigenic squamous cell carcinoma line converted to tumorigenicity with methyl methanesulfonate without activation of HRAS or MYC. Proc Natl Acad Sci USA. 1990;87:1268–72.

    Google Scholar 

  • Milo GE, Shuler C, Stoner G, Chen J-C. Conversion of premalignant human cells to tumorigenic cells by methyl methanesulfonate and methylnitrosoguanidine. Cell Biol Toxicol. 1992;8:193–205.

    Google Scholar 

  • Milo GE, Li D, Casto BC et al. Malignant conversion of chemically transformed normal human cells. Proc Natl Acad Sci USA. 1996;93:5229–34.

    Google Scholar 

  • Mitsudomi T, Steinberg SM, Nau MM et al. p53 gene muta-tions in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene. 1992;7:171–80.

    Google Scholar 

  • Mount SM. A catalogue of splice junction sequences. Nucleic Acids Res. 1982;10:459–72.

    Google Scholar 

  • Nigro JM, Baker SJ, Preisinger AC et al. Mutations in the p53 gene occur in diverse human tumour types. Nature. 1989;342:705–8.

    Google Scholar 

  • Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet. 1991;338:1356–9.

    Google Scholar 

  • Parada LF, Hartmut L, Weinberg RA, Wolf D, Rotter V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature. 1984;312:649–51.

    Google Scholar 

  • Pavletich NP, Chambers KA, Pabo CO. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev. 1993;7:2556–64.

    Google Scholar 

  • Plattner R, Anderson MJ, Sato KY, Fasching CL, Der CJ, Stanbridge EJ. Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proc Natl Acad Sci USA. 1996;93:6665–70.

    Google Scholar 

  • Ponchel F, Puisieux A, Tabone E et al. Hepatocarcinoma-specific mutant p53-249ser induces mitotic activity but has no effect on transforming growth factor β1-mediated apoptosis. Cancer Res. 1994;54:2064–8.

    Google Scholar 

  • Quartin RS, Levine AJ. A comparison of the properties of human p53 mutant alleles. In: Yang SS, Warner HR, eds. The underlying molecular cellular, and immunological factors in cancer and aging. New York: Plenum Press; 1993:55–65.

    Google Scholar 

  • Rheinwald JG, Beckett MA. Tumorigenic keratinocytes lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res. 1981;41:1657–63.

    Google Scholar 

  • Ridgway PJ, Hale TK, Braithwaite AW. p53 confers a selective advantage on transfected HeLa cells. Oncogene. 1993;8:1069–74.

    Google Scholar 

  • Rovinski B, Benchimol S. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene. 1988;2:445–52.

    Google Scholar 

  • Rumsby G, Carter RL, Gusterson BA. Low incidence of ras oncogene activation in human squamous cell carcinomas. Br J Cancer. 1990;61:365–8.

    Google Scholar 

  • Sakai E, Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene. 1992;7:927–33.

    Google Scholar 

  • Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Press; 1989.

    Google Scholar 

  • Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977;74:5463–7.

    Google Scholar 

  • Saranath D, Chang SE, Bhoite LT et al. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Br J Cancer. 1991;63:573–8.

    Google Scholar 

  • Shuler C, Kurian P, French BT et al. Noncorrelative c-myc and ras oncogene expression in squamous cell carcinoma cells with tumorigenic potential. Teratogen Carcinogen Mutagen. 1990;10:53–65.

    Google Scholar 

  • Shuler CF, Milo GE. Morphologic and molecular characterizations of plastic tumor cell phenotypes. In: Milo GE, Casto BC, Shuler CF, eds. Transformation of human epithelial cells: molecular and oncogenetic mechanisms. Boca Raton: CRC Press; 1992:211–34.

    Google Scholar 

  • Slingerland JM, Benchimol S. Transforming activity of mutant human p53 alleles. J Cell Physiol. 1991;148:391–5.

    Google Scholar 

  • Slingerland JM, Minden MD, Benchimol S. Mutation of the p53 gene in human acute myelogenous leukemia. Blood. 1991;77:1500–7.

    Google Scholar 

  • Slingerland JM, Jenkins JR, Benchimol S. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J. 1993;12:1029–37.

    Google Scholar 

  • Soussi T, de Fromentel CC, Mechali M, May P, Kress M. Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. Oncogene. 1987;1:71–8.

    Google Scholar 

  • Sun Y, Nakamura K, Wendel E, Colburn N. Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasophar-yngeal carcinoma. Proc Natl Acad Sci USA. 1993;90:2827–31.

    Google Scholar 

  • Tadokoro K, Ueda M, Ohshima T et al. Activation of onco-genes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc. Oncogene. 1989;4:499–505.

    Google Scholar 

  • Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell. 1992;70:523–6.

    Google Scholar 

  • Williams AC, Browne SJ, Yeudal WA et al. Molecular events including p53 and k-ras alterations in the in vitro progres-sion of a human colorectal adenoma cell line to an adeno-carcinoma. Oncogene. 1993;8:3063–72.

    Google Scholar 

  • Williams AC, Harper SJ, Paraskeva C. Neoplastic transforma-tion of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res. 1990;50:4724–30.

    Google Scholar 

  • Williams AC, Browne SJ, Manning AM, Daffada P, Collard TJ, Paraskeva C. Transfection and expression of mutant p53 protein does not alter the in vivo or in vitro growth characteristics of the AA/C1 human adenoma derived cell line, including sensitivity to transforming growth factor-b1. Oncogene. 1994;9:1479–85.

    Google Scholar 

  • Wolf D, Harris N, Rotter V. Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene. Cell. 1984;38:119–26.

    Google Scholar 

  • Wong Z, Wilson V, Patel I, Povey S, Jeffreys AJ. Characterization of a panel of highly variable minisatellites cloned from human DNA. Ann Human Genet. 1987;51:269–88.

    Google Scholar 

  • Wyllie FS, Lemoine NR, Barton CM, Dawson T, Bond J, Wynford-Thomas D. Direct growth stimulation of normal human epithelial cells by mutant p53. Mol Carcinogen. 1993;7:83–8.

    Google Scholar 

  • Yaginuma Y, Westphal H. Analysis of the p53 gene in human uterine carcinoma cell lines. Cancer Res. 1991;51:6506–9.

    Google Scholar 

  • Yaginuma Y, Westphal H. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines. Cancer Res. 1992;52:4196–9.

    Google Scholar 

  • Zajchowski D, Band V, Pauzie N, Tager A, Stampfer M, Sager R. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells. Cancer Res. 1988;48:7041–7.

    Google Scholar 

  • Zambetti GF, Levine AJ. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 1993;7:885.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Biochemistry and the Comprehensive Cancer Center, Columbus, Ohio, USA

    H. Lee, D. Li, B.C. Casto & G.E. Milo

  2. Department of Pathology, Columbus, Ohio, USA

    T. Prior

  3. School of Public Health, The Ohio State University, Columbus, Ohio, USA

    C.M. Weghorst

  4. Center for Craniofacial Molecular Biology, The University of Southern California, Los Angeles, California, USA

    C.F. Shuler

Authors
  1. H. Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Prior
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B.C. Casto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C.M. Weghorst
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. C.F. Shuler
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G.E. Milo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, H., Li, D., Prior, T. et al. Ineffectiveness of the presence of H-ras/p53 combination of mutations in squamous cell carcinoma cells to induce a conversion of a nontumorigenic to a tumorigenic phenotype. Cell Biol Toxicol 13, 419–434 (1997). https://doi.org/10.1023/A:1007419810705

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007419810705

Search

Navigation